Aclarion Expands CLARITY Trial with Texas Spine Care Center as New Site — Aclarion, Inc.

Event summary

Aclarion adds Texas Spine Care Center as a new clinical site for its CLARITY trial, designed to validate Nociscan’s ability to improve surgical outcomes for chronic low back pain.
Texas Spine Care Center is a high-volume orthopedic spine practice with two locations in San Antonio, focusing on precise pain diagnosis before treatment.
The CLARITY trial is a 300-patient, prospective, randomized study evaluating Nociscan’s clinical and economic value in spine surgery.
Initial internal data readout and early interim results from the CLARITY trial are expected to be disclosed in Q4 2026.

The big picture

Aclarion’s addition of Texas Spine Care Center as a CLARITY trial site underscores the growing interest in precision diagnostics for chronic low back pain. The trial’s success could position Nociscan as a standard tool in spine surgery, addressing a global healthcare problem affecting 266 million people. The strategic alignment with high-volume clinical sites suggests Aclarion is building a robust evidence base to support reimbursement and broader adoption.

What we're watching

Trial Execution: The pace at which Aclarion enrolls patients and generates interim data will determine the timeline for Nociscan’s regulatory and reimbursement approvals.
Clinical Validation: Whether the CLARITY trial successfully demonstrates Nociscan’s ability to improve surgical outcomes could influence its adoption in spine care practices.
Market Expansion: How Aclarion leverages high-profile clinical sites like Texas Spine Care Center and Johns Hopkins University to build credibility and expand its partner network.